Bulletin of the World Health Organization

Use of active management of the third stage of labour in seven developing countries

Cynthia Stanton, Deborah Armbruster, Rod Knight, Iwan Ariawan, Sourou Gbangbade, Ashebir Getachew, Jose Angel Portillo, Douglas Jarquin, Flor Marin, Sayoka Mfinanga, Jesus Vallecillo, Hope Johnson & David Sintasath

Volume 87, Number 3, March 2009, 207-215

Table 5. Correct use of individual components of active management of the third stage of labour in seven developing countries, 2005 and 2006a

Practice Observed deliveries with correct use of AMTSLb
Africa
Asia
Central America
Benin Ethiopia United Republic of Tanzania Indonesia El Salvador Honduras Nicaragua
Components of correct use of a uterotonic drug
Correct stage (i.e. after fetal delivery) (%) 88.6 69.7 37.6 91.5 44.2 51.4 43.9
Correct dose (%) 91.5 73.3 68.9c 77.3 48.5 87.3 91.7
Correct mode of administration (%) 95.9 95.8 84.7 86.3 43.7 95.2 96.6
Correct timing of administration (%) 63.2 40.8 10.4 67.3 13.9 25.1 15.6
Controlled cord traction (%) 65.3 67.8 68.8 80.3 26.4 44.4 17.9
Fundal massage immediately after placental delivery (%) 81.8 72.1 87.6 77.8 61.2 38.7 54.0
Immediate fundal massage, plus palpation of uterus at least twice in 30 min after placental delivery (%) 34.6 8.7 10.4 70.8 23.2 6.1 10.2
Observed deliveries 250 310 249 408 198 221 180
Any use of uterotonic during the 3rd or 4th stage of labour (%) 96.2 99.8 96.8 99.7 60.1 95.7 100.0
Overall correct use of uterotonic for AMTSL purposes (%) 61.3 38.6 6.5 52.6 13.4 20.1 11.5

AMTSL, active management of the third stage of labour.
a Data collected from October to December 2005 for Ethiopia and the United Republic of Tanzania, and from July to December 2006 for the remaining countries.
b According to the FIGO–ICM definition of the AMTSL.
c Correct dose for ergometrine is defined as 0.5 mg only for the United Republic of Tanzania.